scholarly journals Well-being and harm reduction, the consolidated reality of electronic cigarettes ten years later from this emerging phenomenon: A narrative review

2021 ◽  
Vol 8 (3) ◽  
Author(s):  
Pasquale Caponnetto
Keyword(s):  
Smoking Cessation ◽  
Harm Reduction ◽  
Behavioral Treatment ◽  
Electronic Cigarettes ◽  
Well Being ◽  
Cigarette Use ◽  
National Library ◽  
Smoking Cessation Treatment ◽  
Cessation Treatment ◽  
Original Contribution

Tobacco use is the greatest threat to public health worldwide, killing more than seven million people annually. This paper, about 10 years after the first review on electronic cigarettes, analyses the evolution that this tool has had in these years. It concludes with comments on the significance of the research and why it constitutes an original contribution. We searched PubMed (National Library of Medicine), and PsycINFO (Ovid) (2006-2020) for studies on e-cigarettes (harms and benefits, e-cigarette use, craving and smoking cessation) and smoking cessation treatment (smoking cessation treatment or varenicline or tobacco cessation or reduction or bupropion or NRT or behavioral treatment or ecigarette) and evidence suggests that they may effective as smoking cessation tool and may be less harmful alternatives to combustible cigarette smoking. Consequently, e-cigarettes could be considered as an applicable instrument for Tobacco Harm Reduction (THR) and smoking cessation.

scholarly journals Approved and emerging smoking cessation treatments for people with schizophrenia spectrum disorders: A narrative review

2020 ◽  
Vol 8 (2) ◽  
Author(s):  
Pasquale Caponnetto ◽  
Riccardo Polosa
Keyword(s):  
Smoking Cessation ◽  
Behavioral Treatment ◽  
Behavioural Therapy ◽  
Schizophrenia Spectrum Disorders ◽  
Smoking Cessation Treatment ◽  
Schizophrenia Spectrum ◽  
Cessation Treatment ◽  
Original Contribution ◽  
Spectrum Disorders

This review focuses on smoking cessation treatments for people with schizophrenia spectrum disorders. It concludes with comments on the significance of the research and why it constitutes an original contribution. We searched PubMed (National Library of Medicine), and PsycINFO (Ovid) (2006-2020) for studies on schizophrenic disorder (schizophrenia or psychotic or psychosis or severe mental illness) and smoking cessation treatment (smoking cessation treatment or varenicline or tobacco cessation or reduction or bupropion or NRT or behavioral treatment or e-cigarette). Studies found evidence suggesting that pharmacotherapy combined with behavioural therapy for smoking cessation is effective amongst smokers with schizophrenia spectrum disorders, although more long-term research is required. This review summarised and critically reviewed also studies on vaping as a smoking cessation strategy for smokers with schizophrenia spectrum disorders and evidence suggests that they may effective as smoking cessation tool and may be less harmful alternatives to combustible cigarette smoking. Consequently, e-cigarettes could be considered as an applicable instrument for Tobacco Harm Reduction (THR) and smoking cessation. Overall, there are very few studies of e-cigarettes for smoking cessation in patients with schizophrenia and these studies are very small. They have promising results, but more research is needed.

scholarly journals Beliefs, Attitudes, and Confidence to Deliver Electronic Cigarette Counseling among 1023 Chinese Physicians in 2018

2019 ◽  
Vol 16 (17) ◽  
pp. 3175
Author(s):  
Yitian Feng ◽  
Fan Wang ◽  
Abu S. Abdullah ◽  
Xiaoyan Wang ◽  
Jing Wang ◽  
...  
Keyword(s):  
Smoking Cessation ◽  
Health Effects ◽  
Electronic Cigarettes ◽  
Routine Practice ◽  
Cigarette Use ◽  
Smoking Cessation Treatment ◽  
Adverse Health Effects ◽  
Adverse Health ◽  
Cessation Treatment ◽  
Chinese Physicians

Background: The use of electronic cigarettes (e-cigarettes) is gaining popularity, so it is important to evaluate physicians’ understanding of e-cigarettes. This study assessed the beliefs, attitudes, and confidence in e-cigarette counseling among Chinese physicians and explored the factors related to asking patients about e-cigarette use. Methods: Physicians from across China were invited to participate in a questionnaire survey using the platform provided by DXY (www.dxy.cn) in 2018. In total, 1023 physicians completed the online survey. Descriptive analyses were used to characterize the participants, and multivariate logistic regression analyses were applied to identify predictors of physicians’ asking about patients’ e-cigarette use. Results: Only 46.3% of respondents agreed that e-cigarettes had adverse health effects, and 66.8% indicated that e-cigarettes can be regarded as a type of smoking cessation treatment. We found that 61.3% thought it was important to discuss e-cigarettes with patients, and 71.7% reported feeling confident about their ability in counseling about e-cigarettes. Respondents who had used e-cigarettes (OR = 2.05; 95% CI: 1.16–2.63), had received training about e-cigarettes (OR = 3.13; 95% CI: 2.17–4.52), or were confident about their ability to answer patients’ question about e-cigarettes (OR = 2.45; 95% CI: 1.65–3.65) were more likely to ask patients about e-cigarette use. Physicians who showed a supportive attitude toward using e-cigarettes to quit smoking (OR = 0.79; 95% CI: 0.63–0.99) were less likely to ask about patients’ e-cigarettes use frequently. Conclusions: Chinese physicians appeared to ignore the adverse health effects of e-cigarettes, and considered e-cigarettes as a smoking cessation treatment. Comprehensive training and regulations are needed to help physicians incorporate the screening of e-cigarette use into routine practice and provide patients truthful information as new data emerge.

scholarly journals Electronic cigarettes in standard smoking cessation treatment by tobacco counselors in Flanders: E-cigarette users show similar if not higher quit rates as those using commonly recommended smoking cessation aids

2021 ◽  
Vol 18 (1) ◽  
Author(s):  
Karolien Adriaens ◽  
Eline Belmans ◽  
Dinska Van Gucht ◽  
Frank Baeyens
Keyword(s):  
Smoking Cessation ◽  
Cohort Study ◽  
Replacement Therapy ◽  
Electronic Cigarettes ◽  
Evidence Based ◽  
Smoking Abstinence ◽  
Smoking Cessation Treatment ◽  
Cessation Treatment ◽  
Point Prevalence Abstinence

Abstract Background This interventional-cohort study tried to answer if people who smoke and choose an e-cigarette in the context of smoking cessation treatment by tobacco counselors in Flanders are achieving smoking abstinence and how they compare to clients who opt for commonly recommended (or no) aids (nicotine replacement therapy, smoking cessation medication). Methods Participants were recruited by tobacco counselors. They followed smoking cessation treatment (in group) for 2 months. At several times during treatment and 7 months after quit date, participants were asked to fill out questionnaires and to perform eCO measurements. Results One third of all participants (n = 244) achieved smoking abstinence 7 months after the quit date, with e-cigarette users having higher chances to be smoking abstinent at the final session compared to NRT users. Point prevalence abstinence rates across all follow-up measurements, however, as well as continuous and prolonged smoking abstinence, were similar in e-cigarette users and in clients having chosen a commonly recommended (or no) smoking cessation aid. No differences were obtained between smoking cessation aids with respect to product use and experiences. Conclusions People who smoke and choose e-cigarettes in the context of smoking cessation treatment by tobacco counselors show similar if not higher smoking cessation rates compared to those choosing other evidence-based (or no) smoking cessation aids.

Correlates of e-cigarette use among adults initiating smoking cessation treatment

2021 ◽  
Vol 224 ◽  
pp. 108724
Author(s):  
Laili Kharazi Boozary ◽  
Summer G. Frank-Pearce ◽  
Adam C. Alexander ◽  
Joseph J.C. Waring ◽  
Sarah J. Ehlke ◽  
...  
Keyword(s):  
Smoking Cessation ◽  
Cigarette Use ◽  
Smoking Cessation Treatment ◽  
Cessation Treatment

scholarly journals The Preliminary Efficacy and Feasibility of Group-Based Smoking Cessation Treatment Program for Incarcerated Smokers

2020 ◽  
Vol 14 (4) ◽  
pp. 155798832094335
Author(s):  
Pamela Valera ◽  
Nicholas Acuna ◽  
Ismary Vento
Keyword(s):  
Smoking Cessation ◽  
Treatment Program ◽  
Group Treatment ◽  
Electronic Cigarettes ◽  
Smoking Status ◽  
Exhaled Breath ◽  
Smoking Cessation Treatment ◽  
Nicotine Patches ◽  
Cessation Treatment

Group-based tobacco dependence treatment has been known to help smokers to quit in general adult populations, but the feasibility and efficacy of this type of smoking cessation treatment in correctional settings remain uncertain. A 6-week group-based smoking cessation treatment with nicotine replacement therapy (NRT) in the form of nicotine patches was implemented in seven male prison facilities, in the Northeast, among smokers who were born biologically as male. Exhaled breath carbon monoxide (CO) levels were collected from participants at each session to confirm smoking status. Participants were evaluated at the 1-month post-group treatment follow-up to determine abstinence. Those who were lost to follow-up were recorded as continued smoking and not using NRT nicotine patches. The goal of the study was to explore the feasibility and preliminary efficacy of conducting a smoking cessation treatment program for incarcerated smokers. A total of 350 inmates were screened, 177 inmates were enrolled across the prison sites for the 6-week program, and 102 inmates completed the program. A majority of those enrolled reported that they began smoking when they were between 15 and 19 years of age (44.9%) and were smoking on average for 26 years. Less than half (21.3%) reported ever using electronic cigarettes at baseline and in Session 1,116 individuals who attended reported a median CO level of 18.0 parts per million (ppm). At a 1-month follow-up, 43 individuals reported a median CO level of 5.00 ppm. The study demonstrated preliminary efficacy and feasibility of group-based smoking cessation treatment with NRT nicotine patches in incarcerated smokers.

scholarly journals Corrigendum to “Correlates of e-cigarette use among adults initiating smoking cessation treatment” [Drug Alcohol Depend. 224 (2021) 108724]

2021 ◽  
Vol 228 ◽  
pp. 109035
Author(s):  
Laili Kharazi Boozary ◽  
Summer G. Frank-Pearce ◽  
Adam C. Alexander ◽  
Joseph J.C. Waring ◽  
Sarah J. Ehlke ◽  
...  
Keyword(s):  
Smoking Cessation ◽  
Cigarette Use ◽  
Smoking Cessation Treatment ◽  
Cessation Treatment

Evaluation of a web-based cognitive behavioral smoking cessation treatment for overweight/obese smokers

2017 ◽  
Vol 24 (13) ◽  
pp. 1796-1806 ◽  
Author(s):  
Marney A White ◽  
Valentina Ivezaj ◽  
Carlos M Grilo
Keyword(s):  
Smoking Cessation ◽  
Behavioral Treatment ◽  
Standard Treatment ◽  
Cognitive Behavioral ◽  
Cognitive Behavioral Treatment ◽  
Web Based ◽  
Smoking Cessation Treatment ◽  
Cessation Treatment ◽  
Community Volunteers

This pilot study tested the efficacy of an Internet-administered smoking cessation treatment for overweight/obese smokers. Participants were 54 community volunteers with overweight/obesity who were regular smokers. Treatment consisted of 12 weeks of nicotine replacement therapy and randomization to Internet-administered cognitive behavioral treatment or health education. In-person assessments of key outcomes occurred at baseline, post-treatment, and at 24-week follow-up. Cessation rates did not differ across the two treatments (25.9% vs 18.5%). Participants receiving cognitive behavioral treatment gained less weight when abstinent than those receiving the standard treatment. Larger studies are needed to replicate these findings.

Sign in / Sign up

Export Citation Format

Share Document